Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment
- PMID: 3986807
Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment
Abstract
The epidermal and dermal effects of protracted 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment (2 micrograms TPA twice weekly) of Sencar mouse skin were studied using cell kinetics and morphometric techniques. In addition, regression of TPA-induced changes was evaluated after cessation of 56 topical applications. During the first week of treatment a reactional hyperplasia, characterized by cell damage, edema, and acute inflammation in both epidermis and dermis, occurred. This picture changed gradually during the following 3 weeks: an epidermal hyperplasia devoid of involutional or inflammatory features was accompanied by a moderate to mild chronic inflammation of the dermis and a hyperplasia of the hair follicles. This remained throughout the experimental period until the topical TPA treatment ceased. Although TPA induced papillomas in only 5% of the animals (maximum = 2 papillomas/animal and no carcinomas), all sustained marked epidermal hyperplasia of approximately 4 to 5 times the normal thickness, and increased the number and volume of hair follicles. The [3H]thymidine pulse-labeling index of the basal layer was approximately 32% (normal congruent to 6%). The level of dark keratinocytes remained constant; i.e., 8% of the basal cells were identified as dark cells during the entire experiment. At the subepidermal level the dermal thickness and total cellularity increased, although the proportion of the different cell types changed during the treatment. The mast cell population increased remarkably. After TPA treatment ceased, most of these parameters regressed abruptly during the first 2 weeks. Two to 4 months later, the epidermis was slightly thinner, and the labeling index was 50% lower than normal (2.8%). This study shows that prolonged repetitive TPA applications induced a steady-state hyperplasia without tachyphylaxis, and that this alteration regressed rapidly after treatment ceased. In addition, labeling-index values lower than normal were reached soon after normalization, suggesting that a possible selection of keratinocytes, dependent on TPA for proliferation, took place during the chronic administration of topical TPA. The number of hair follicle, capillary vessels, mast cells, and the dermal thickness never reached normal values after treatment. These important changes in the dermis and hair follicles indicate that the target cells for tumor promoters are not confined to the epidermis alone, and that these tissues could participate actively in carcinogenesis directly, either as tumor-originating tissues (hair follicles), or as inducers or helpers of neoplastic growth (connective tissue cells).
Similar articles
-
NTP Toxicology and Carcinogenesis Studies of 1,2-Dihydro-2,2,4-Trimethylquinoline (CAS No. 147-47-7) in F344/N Rats and B6C3F1 Mice (Dermal Studies) and the Dermal Initiation/Promotion Study in Female Sencar Mice.Natl Toxicol Program Tech Rep Ser. 1997 Feb;456:1-312. Natl Toxicol Program Tech Rep Ser. 1997. PMID: 12587020
-
A morphometric study of dedifferentiated and involutional dark keratinocytes in 12-O-tetradecanoylphorbol-13-acetate-treated mouse epidermis.Cancer Res. 1984 Jun;44(6):2711-7. Cancer Res. 1984. PMID: 6202399
-
Differential down-regulation of epidermal protein kinase C by 12-O-tetradecanoylphorbol-13-acetate and diacylglycerol: association with epidermal hyperplasia and tumor promotion.Cancer Res. 1990 Sep 15;50(18):5740-5. Cancer Res. 1990. PMID: 2393848
-
Cellular and biochemical changes during multistage skin tumor promotion.Princess Takamatsu Symp. 1983;14:291-301. Princess Takamatsu Symp. 1983. PMID: 6394592 Review.
-
Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.Int J Toxicol. 2007;26 Suppl 3:1-30. doi: 10.1080/10915810701663143. Int J Toxicol. 2007. PMID: 18273450 Review.
Cited by
-
A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy.Nature. 2018 Oct;562(7727):434-438. doi: 10.1038/s41586-018-0603-3. Epub 2018 Oct 8. Nature. 2018. PMID: 30297799 Free PMC article.
-
Effects of chronic topical application of 12-O-tetradecanoylphorbol-13-acetate on the skin and internal organs of SENCAR mice.Environ Health Perspect. 1986 Sep;68:75-80. doi: 10.1289/ehp.866875. Environ Health Perspect. 1986. PMID: 3780635 Free PMC article.
-
Inducible and cell type-specific expression of VL30 U3 subgroups correlate with their enhancer design.J Virol. 1994 Jan;68(1):276-88. doi: 10.1128/JVI.68.1.276-288.1994. J Virol. 1994. PMID: 8254739 Free PMC article.
-
Lymphatic endothelial cells attenuate inflammation via suppression of dendritic cell maturation.Oncotarget. 2016 Jun 28;7(26):39421-39435. doi: 10.18632/oncotarget.9820. Oncotarget. 2016. PMID: 27270646 Free PMC article.
-
Cyclosporine is angiostatic.Experientia. 1992 Dec 1;48(11-12):1135-8. doi: 10.1007/BF01948007. Experientia. 1992. PMID: 1282107
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources